SCHEMBL27675460

SCHEMBL27675460

Cc1ccc(F)c2c1CCN(S(=O)(=O)c1ccc(Oc3ccc(Cl)cc3)cc1)C2NC(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 7/20 0.43
MMP1 P03956 7/20 0.43
MMP2 P08253 4/20 0.43
MMP3 P08254 3/20 0.43
MMP8 P22894 3/20 0.42
MMP12 P39900 1/20 0.42
MMP14 P50281 1/20 0.42
MAPT P10636 1/20 0.41
ADAM17 P78536 5/20 0.39
HCRTR1 O43613 5/20 0.39
HCRTR2 O43614 5/20 0.39
MMP13 P45452 2/20 0.38
PSEN1 P49768 1/20 0.37
PSEN2 P49810 1/20 0.37
APH1B Q8WW43 1/20 0.37
NCSTN Q92542 1/20 0.37
APH1A Q96BI3 1/20 0.37
PSENEN Q9NZ42 1/20 0.37
BCL2L1 Q07817 1/20 0.37
MCL1 Q07820 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27693820 1.00 MMP9 (0.43) MMP9MMP1MMP2MMP3MMP8
SCHEMBL27675438 1.00 MMP9 (0.43) MMP9MMP1MMP2MMP3MMP8
SCHEMBL27675463 0.93 MMP1 (0.46) MMP9MMP1MMP2MMP3MMP14
SCHEMBL27675486 0.93 MMP1 (0.46) MMP9MMP1MMP2MMP3MMP14
SCHEMBL14427240 0.87 MMP8 (0.43) MMP9MMP1MMP2MMP3MMP8
SCHEMBL14427239 0.84 MMP1 (0.51) MMP9MMP1MMP2MMP3MMP8
SCHEMBL5164149 0.83 MMP1 (0.45) MMP9MMP1MMP2MMP3MMP8
SCHEMBL5188709 0.83 MMP1 (0.45) MMP9MMP1MMP2MMP3MMP8
SCHEMBL5160889 0.83 MMP1 (0.45) MMP9MMP1MMP2MMP3MMP8
SCHEMBL5437193 0.82 MMP8 (0.41) MMP9MMP1MMP2MMP3MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101006059-A Substituted tetrahydroisoquinolines for use as MMP inhibitors, method for the production thereof, and use thereof in the form of medicaments SANOFI AVENTIS DEUTSCHLAND (DE) 2007-07-25 CN disclosed